Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum: Effects of amyloid β peptide

Molecular and Chemical Neuropathology

Volumn 35, Issue 1-3, 1998, Pages 77-95

  Chalimoniuk, Malgorzata ^a   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

AGING; ANIMAL TISSUE; ARTICLE; CEREBELLUM; DEPRESSION; HIPPOCAMPUS; LEARNING; LONG TERM POTENTIATION; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-3-ISOBUTYLXANTHINE; 2-AMINO-5-PHOSPHONOVALERATE; AGING; AMYLOID BETA-PROTEIN; ANIMALS; CEREBELLUM; CEREBRAL CORTEX; CYCLIC GMP; DIZOCILPINE MALEATE; GUANYLATE CYCLASE; HIPPOCAMPUS; INDAZOLES; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 0032914204     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815117     Document Type: Article

References (41)

1. + channels reverses the inhibitory action of atriopeptin on secretagogue-stimulated ACTH release by perifused isolated rat anterior pituitary cells. J. Endocrinol. 126, 183-191.
2. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
3. Bernabeu R., Schroder N., Quevedo J., Cammarota M., Izquierdo I., and Medina J. H. (1997) Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. NeuroReport 8, 2221-2224.
4. Bonkale W. L., Winblad B., Ravid R., and Cowburn R. F. (1995) Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease. Neurosci. Lett. 187, 5-8.
5. Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
6. Brown J. and Czarnecki A. (1990) Autoradiographic localization of atrial and brain natriuretic peptide receptors in rat brain. Am. J. Physiol. 258, R57-R63.
7. Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., and Boulu R. G. (1993) Nitric oxide: an endogenous anticonvulsant substance. NeuroReport 4, 444-446.
8. Chalimoniuk M. and Strosznajder J. (1997) Aging decreases the basal level of cGMP and eliminates NMDA receptor dependent cGMP formation in hippocampus and cerebellum; effect of amyloid β. J. Neurochem. 69 Suppl., S180B-S180B (Abstract).
9. Collingridge G. L. and Singer W. (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11, 290-296.
10. Constantine-Paton M., Cline H. T., and Debski E. (1990) Patterned activity, synaptic convergence, and the NMDA receptor in developing visual pathways. Annu. Rev. Neurosci. 13, 129-154.
11. Deguchi T. (1977) Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. J. Biol. Chem. 252, 7617-7619.
12. Deguchi T. and Yoshioka M. (1982) L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol. Chem. 257, 10,147-10,151.
13. 2+ current through a mechanism independent of cGMP-dependent protein kinase. Neuron 1, 693-699.
14. Fiez J. A. (1996) Cerebellar contributions to cognition. Neuron 16, 13-15.
15. Forstermann U., Schmidt H. H., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., et al. (1991) Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42, 1849-1857.
16. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein. Nature 379, 74-78.
17. Gally J. A., Montague P. R., Reeke G. N. Jr., and Edelman G. M. (1990) The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc. Natl. Acad. Sci. USA 87, 3547-3551.
18. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
19. Garthwaite J. and Boulton C. L. (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683-706.
20. Garthwaite G. and Garthwaite J. (1988) Cyclic GMP and cell death in rat cerebellar slices. Neuroscience 26, 321-326.
21. Garthwaite J., Charles S. L., and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336, 385-388.
22. Hirata M., Kohse K. P., Chang C. H., Ikebe T., and Murad F. (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265, 1268-1273.
23. Hosli E. and Hosli L. (1992) Autoradiographic localization of binding sites for arginine vasopressin and atrial natriuretic peptide on astrocytes and neurons of cultured rat central nervous system. Neuroscience 51, 159-166.
24. Hu J. and El-Fakahany E. E. (1993) Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J. Neurochem. 61, 578-585.
25. Johnston H. M. and Morris B. J. (1994) NMDA and nitric oxide increase microtubule-associated protein 2 gene expression in hippocampal granule cells. J. Neurochem. 63, 379-382.
26. Knowles R. G., Palacios M., Palmer R. M., and Moncada S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86, 5159-5162.
27. Luscher T. F., Tanner F. C., and Doha Y. (1992) Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol. Toxicol. 70, S32-S39.
28. Malenka R. C. (1994) Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78, 535-538.
29. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., and Fagni L. (1992) Nitric oxide-induced blockade of NMDA receptors. Neuron 8, 653-662.
30. 2+ current modulated by cGMP-dependent protein kinase [published erratum appears in Nature Oct 27, 1994; 371(6500):812]. Nature 369, 336-339.
31. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA 88, 1197-1201.
32. Miki N., Kawabe Y., and Kuriyama K. (1977) Activation of cerebral guanylate cyclase by nitric oxide. Biochem. Biophys. Res. Commun. 75, 851-856.
33. Monaghan D. T., Bridges R. J., and Cotman C. W. (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29, 365-402.
34. Schamahmana J. D. (1994) Neurobiology of Autism (Bauman M. L. and Kemper T. L., eds.), pp. 195-226, Johns Hopkins University Press, Baltimore.
35. Shibuki K. and Okada D. (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349, 326-328.
36. Tamaru M., Yoneda Y., Ogita K., Shimizu J., and Nagata Y. (1991) Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 542, 83-90.
37. Vincent T. (1995) Nitric Oxide in the Nervous System, Academic Press, London.
38. Wahler G. M., Rusch N. J., and Sperelakis N. (1990) 8-Bromo-cyclic GMP inhibits the calcium channel current in embryonic chick ventricular myocytes. Can. J. Physiol. Pharmacol. 68, 531-534.
39. Wang X. and Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443-456.
40. White R. E., Lee A. B., Shcherbatko A. D., Lincoln T. M., Schonbrunn A., and Armstrong D. L. (1993) Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 361, 263-266.
41. Zhuo M., Hu Y., Schultz C., Kandel E. R., and Hawkins R. D. (1994) Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368, 635-639.